CG
CAB Garcia

Emerging

16
Works
0
Citations
0
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5083265994
  • i10-Index 0
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

CAB Garcia

Also known as: CAB Garcia

16

Total Works

0

Citations

0

H-Index

0

i10-Index

Citation & Works Trend by Year
4 years active
Top Research Topics
Acute Myeloid Leukemia Research (11) Immune Cell Function and Interaction (7) Retinoids in leukemia and cellular processes (7) Chronic Myeloid Leukemia Treatments (6) Myeloproliferative Neoplasms: Diagnosis and Treatment (5)
Recent Publications
15 shown
Year Publication Title Citations Action
2025 FLT3-ITD MUTATION PROMOTES LEUKEMIC DIFFERENTIATION TOWARDS AN IMMATURE CYTOTOXIC STAGE Hematology Transfusion and Cell Therapy 0
2025 EXPLORATION OF MUTATIONAL PATTERNS AND THEIR IMPACT ON THE IMMUNE EXPLORATION OF MUTATIONAL PATTERNS AND THEIR IMPACT ON THE IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA THROUGH IN SILICO ANALYSES Hematology Transfusion and Cell Therapy 0
2025 IMMUNE MATURATION AND CHECKPOINT DYNAMICS DURING TYROSINE KINASE INHIBITOR DOSE REDUCTION PREDICT RELAPSE RISK IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDERGOING TREATMENT DISCONTINUATION Hematology Transfusion and Cell Therapy 0
2025 IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSIS Hematology Transfusion and Cell Therapy 0
2024 IMMUNOPHENOTYPIC SIGNATURE OF LEUKEMIA ARREST STAGE IS ASSOCIATED WITH NPM1/FLT3 MUTATIONAL PROFILE AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA Hematology Transfusion and Cell Therapy 0
2024 IMPACT OF NK RECEPTOR AND LIGAND GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA: A COMPUTATIONAL APPROACH Hematology Transfusion and Cell Therapy 0
2024 CYTOTOXIC IMMUNE CELLS MATURATION IN MYELOFIBROSIS: IMPLICATIONS FOR DISEASE PROGRESSION Hematology Transfusion and Cell Therapy 0
2024 IMMUNOLOGICAL PROFILES OF CYTOTOXIC CELLS IS ASSOCIATED WITH TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA Hematology Transfusion and Cell Therapy 0
2024 HIGH LEUKEMIC STEM CELL FREQUENCY IN FLT3- MUTATED ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE: IMPLICATIONS FOR PROGNOSIS Hematology Transfusion and Cell Therapy 0
2023 RECLASSIFICAÇÃO DA LEUCEMIA MIELOIDE AGUDA DE ACORDO COM A CÉLULA DE ORIGEM FENOTIPICAMENTE DEFINIDA Hematology Transfusion and Cell Therapy 0
2023 MATURAÇÃO FUNCIONAL E ATIVAÇÃO DE CÉLULAS NATURAL KILLER DISTINGUEM MIELOFIBROSE PRÉ-FIBRÓTICA E FIBRÓTICA Hematology Transfusion and Cell Therapy 0
2023 AVALIAÇÃO DE VIABILIDADE DE DETECÇÃO DE DRM EM LLA-B POR CITOMETRIA DE FLUXO MULTIPARAMÉTRICA INDEPENDENTE DE CD19 Hematology Transfusion and Cell Therapy 0
2023 EXPOSIÇÃO À MEDULA ÓSSEA JAK2V617F LEVA À DISFUNÇÃO DE CÉLULAS NK NORMAIS Hematology Transfusion and Cell Therapy 0
2023 FREQUÊNCIA E ATIVAÇÃO DE CÉLULAS CITOTÓXICAS ANTITUMORAIS SÃO BIOMARCADORES DE RESPOSTA E REMISSÃO LIVRE DE TRATAMENTO NA LEUCEMIA MIELOIDE CRÔNICA Hematology Transfusion and Cell Therapy 0
2022 A EXPRESSÃO DIFERENCIAL DE CÉLULAS PROGENITORAS LEUCÊMICAS DEFINIDAS POR CD99/CD123 ESTÁ ASSOCIADA À MUTAÇÃO FLT3-ITD E RECAÍDA NA LEUCEMIA MIELOIDE AGUDA Hematology Transfusion and Cell Therapy 0

Data source: OpenAlex API